Dr. Danielle Schenone Wallace, MD

Dr. Wallace practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Wallace's NPI, 1982058293, was assigned on April 22, 2016. Dr. Wallace graduated from SUNY Upstate Medical University in 2016. Dr. Wallace holds New York license 290482.

Dr. Wallace's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Wallace's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Wallace to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wallace practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wallace's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wallace is board certified in hematology by the American Board of Internal Medicine. Dr. Wallace is licensed in New York.

Dmand AI lists chronic anemia, chronic obstructive pulmonary disease (COPD), joint pain and sepsis among the conditions Dr. Wallace treats.

CMS data shows 300 Medicare services from Dr. Wallace across 7 procedure codes in 2024, for 72 Medicare patients. Medicare paid $20,146 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Wallace in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wallace's median patient age at 69, with 47% women.

In 2024, Dr. Wallace wrote 154 Medicare Part D claims for 25 patients. 92% of them were for generic drugs. CMS names the drug for 82 of them, across 5 drugs with 11 or more claims each, at $13,673 in total drug cost.

Dr. Wallace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wallace as offering telehealth.

Dmand AI links 14 papers to Dr. Wallace, published from 2020 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Leukemia, Lymphocytic, Chronic, B-Cell and Antineoplastic Agents. Dr. Wallace has published most often in Blood. Dr. Wallace's most frequent co-authors are Paul Michael Barr, MD, Carla Casulo, MD and Clive S. Zent, MD.

CMS Open Payments shows 5 general payments to Dr. Wallace from 1 drug or device company in 2025. Consulting fees make up the largest share, 100% of the total. Acrotech Biopharma LLC paid the most, $3,961.

Dr. Wallace graduated from SUNY Upstate Medical University in 2016.

Dr. Wallace is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and MVP Health Care. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.